A detailed history of Headinvest, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Headinvest, LLC holds 18,347 shares of BMY stock, worth $1.06 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,347
Previous 19,443 5.64%
Holding current value
$1.06 Million
Previous $807,000 17.6%
% of portfolio
0.18%
Previous 0.16%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$39.66 - $51.75 $43,467 - $56,718
-1,096 Reduced 5.64%
18,347 $949,000
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $43,148 - $56,805
1,072 Added 5.84%
19,443 $807,000
Q1 2024

Aug 14, 2024

BUY
$47.98 - $54.4 $96,871 - $109,833
2,019 Added 12.35%
18,371 $996,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $82,949 - $98,981
-1,711 Reduced 9.47%
16,352 $839,000
Q3 2023

Dec 11, 2023

SELL
$57.89 - $64.73 $62,521 - $69,908
-1,080 Reduced 5.64%
18,063 $1.05 Million
Q2 2023

Aug 23, 2023

SELL
$63.71 - $70.74 $623,529 - $692,332
-9,787 Reduced 33.83%
19,143 $1.22 Million
Q1 2023

May 17, 2023

SELL
$65.71 - $74.53 $113,349 - $128,564
-1,725 Reduced 5.63%
28,930 $2.01 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $181,745 - $215,212
2,654 Added 9.48%
30,655 $2.21 Million
Q3 2022

Dec 28, 2022

SELL
$0.13 - $76.84 $6 - $3,842
-50 Reduced 0.18%
28,001 $1.99 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $25,780 - $28,392
355 Added 1.28%
28,051 $2.16 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $54,901 - $65,831
893 Added 3.33%
27,696 $2.02 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $12,871 - $15,004
-240 Reduced 0.89%
26,803 $1.67 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $54,436 - $63,765
920 Added 3.52%
27,043 $1.6 Million
Q2 2021

Aug 30, 2021

BUY
$61.91 - $67.42 $103,203 - $112,389
1,667 Added 6.82%
26,123 $1.75 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $164,965 - $185,537
2,780 Added 12.83%
24,456 $1.54 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $154,165 - $174,698
-2,670 Reduced 10.97%
21,676 $1.31 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $154,165 - $174,698
2,670 Added 12.32%
24,346 $1.51 Million
Q3 2020

Nov 24, 2020

BUY
$57.43 - $63.64 $104,063 - $115,315
1,812 Added 9.12%
21,676 $1.31 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $127,017 - $148,496
2,317 Added 13.2%
19,864 $1.17 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $245,780 - $357,176
5,297 Added 43.24%
17,547 $978,000
Q1 2020

May 11, 2020

BUY
$46.4 - $67.43 $13,224 - $19,217
285 Added 2.38%
12,250 $682,000
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $379,655 - $495,225
7,715 Added 181.53%
11,965 $768,000
Q3 2019

Nov 21, 2019

SELL
$42.77 - $50.71 $342,160 - $405,680
-8,000 Reduced 65.31%
4,250 $216,000
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $552,720 - $659,050
-12,250 Reduced 50.0%
12,250 $584,000
Q4 2018

Feb 22, 2019

BUY
$48.76 - $63.23 $577,806 - $749,275
11,850 Added 93.68%
24,500 $1.27 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $4,249 - $4,793
-77 Reduced 0.61%
12,650 $785,000
Q2 2018

Aug 09, 2018

SELL
$50.53 - $62.98 $2,425 - $3,023
-48 Reduced 0.38%
12,727 $704,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $705,563 - $814,278
12,775
12,775 $788,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Headinvest, LLC Portfolio

Follow Headinvest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.